PLA2G1B and obesity disorder: Thus, perturbation of this process by gene disruption (Pla2g1b−/−) or pharmacological inhibition of sPLA2-IB led to protection from diet-induced obesity and insulin resistance due to decreased lipid digestion and absorption in the gut [75,76].